top of page


A significant breakthrough has been made in cannabis research with the identification of Delta 9-Tetrahydrocannabiphorol (THCP), a new compound among the hundreds of phytocannabinoids in cannabis. THCP, having 30 times the effects of THC, the most famous psychoactive compound, is relatively unknown, raising concerns among experts about its high potency and potential effects on users.


Considering that increased THC levels have been associated with stress, panic attacks, and paranoia in some individuals, the potential effect of THCP, a stronger cannabinoid, must be taken into account.


Despite these concerns, the finding of THCP is a promising step forward for medicinal cannabis. The significant potency of THCP may prove highly advantageous for medical patients, as it implies that smaller doses could effectively provide the desired therapeutic effects. Despite the promising potential of THCP, there remains a considerable amount of information that is yet to be discovered about its characteristics and applications.


The market availability of THCP products for medicinal use is still undetermined. It is uncertain if these products will ever be available in the market. Additional studies are required to pinpoint the cannabis strains containing high levels of THCP and to explore how to optimally utilize them for the advantage of medical cannabis users.


To sum up, the recent identification of THCP in cannabis research marks a substantial breakthrough, yet there is still a lot to discover about this new compound and its impact on the human body. Through continuous investigation, we can deepen our knowledge of THCP and how medical cannabis can benefit patients.

bottom of page